RxDoctor Payments Data

Kenneth Savage, DO

Family Medicine · Crystal River, FLNPI 1588813661

Payments from drug & device makers

$586in general payments, 2019–2025

Across 25 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$305
  • Novo Nordisk$48
  • Pfizer$46
  • Esperion Therapeutics, Inc.$45
  • Sunovion Pharmaceuticals Inc.$25
  • AbbVie$21
  • plus $97 from 6 others

What the payments were for

  • Food & beverage$57398%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$586 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$860,941
Medicare patients
1,377
Services billed
31,884

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$54,541
MounjaroTirzepatide19$36,063
XareltoRivaroxaban28$31,949
JardianceEmpagliflozin18$30,162
OzempicSemaglutide26$27,804
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$21,554
Dabigatran EtexilateDabigatran Etexilate Mesylate40$17,126
FarxigaDapagliflozin Propanediol14$14,402
EntrestoSacubitril/Valsartan13$9,721
Atorvastatin Calcium623$7,269
Albuterol Sulfate HfaAlbuterol Sulfate252$6,586
Gabapentin211$5,420
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$5,347
Fentanyl11$5,153
SymbicortBudesonide/Formoterol Fumarate13$5,144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$46$55,97058 claims
Johnson & JohnsonXarelto$18$31,94928 claims
Novo NordiskOzempic$48$27,80426 claims
GSKTrelegy Ellipta$15$21,55419 claims
NovartisEntresto$17$9,72113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Crystal River

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →